The roseroot herb (Rhodiola rosea) may be a beneficial treatment option for major depressive disorder (MDD), a study published in Phytomedicine has shown.
Results from a large birth cohort study suggest women may not be consuming enough omega-3 to meet the recommendations for pregnancy and lactation.
A specific drug class for the treatment of type 2 diabetes has been linked to an increased risk of weight gain, and researchers have new clues as to how these medications may activate sensors in the brain that lead to increased hunger.
Vitamin D3 and metformin have individually shown promise in reducing the risk of colorectal cancer, but a new study in the journal Cancer Prevention Research indicates that combined use may be significantly more effective than either vitamin D or metformin alone.
Researchers from the University of Kansas Medical Center have found that drinking milk may be linked to levels of glutathione in the brains of healthy older adults.
Zinc deficiency may be linked to chronic diseases that involve inflammation, new research has shown.
The main ingredient found in Sweet 'N Low, Sweet Twin, and Necta may potentially lead to the development of oncology drugs to treat aggressive cancers.
Certain interventions were more successful than others in improving obesity-related outcomes, according to a recent review published in Obesity Reviews.
After completing its evaluation, the U.S. Food and Drug Administration (FDA) concluded that two varieties of apples and six varieties of potatoes, all of which were genetically engineered, are as safe and nutritious as their conventional counterparts.
The MIND diet may significantly reduce the risk of developing Alzheimer's disease even if the diet is not rigorously followed, an article has shown.
Emisphere Technologies announced the launch of Eligen B12 (cyanocobalamin 100mcg, salcaprozate sodium [SNAC] 100mg) for the dietary management of patients who have a vitamin B12 deficiency associated with a disease or condition that cannot be managed by a modification of the normal diet alone.
An article published in The American Journal of Medicine has identified four factors that may negatively impact the delivery of chronic disease care in the U.S. and proposed changes to the model for improving treatment to the estimated 48 percent of the total population that will suffer from chronic disease by 2020.
New evidence has emerged exploring the relationship between gut microbiome, autism spectrum disorder (ASD), and probiotic treatment.
Vertex Pharmaceuticals announced that the Food and Drug Administration (FDA) has approved Kalydeco (ivacaftor) for use in children ages 2-5 with cystic fibrosis (CF) who have one of 10 mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene.
Improved adherence to the Mediterranean diet may reduce the incidence of cognitive decline, dementia, and Alzheimer's disease, a new analysis published in Advances in Nutrition suggest.
Thiamin (vitamin B1) deficiency was found in up to one-third of obese patients seeking bariatric surgery, according to data from a large-scale study.
An increase in diet soda consumption is directly linked to greater visceral adiposity in older adults, reports a new study in the Journal of the American Geriatrics Society.
A new study suggests consuming a high-caloric breakfast and a more modest dinner may suppress blood glucose spikes throughout the day.
While trials on the efficacy of zinc lozenges for cold symptoms have led to mixed results, a new meta-analysis has found that high-dose zinc acetate lozenges may reduce the duration of some cold symptoms by nearly 50 percent.
The combined use of enalapril and folic acid significantly reduced the risk of first stroke compared with enalapril alone, a study published in the JAMA has shown.
Young adults who don't regularly consume caffeine had a higher increase in resting blood pressure after drinking a commercially available energy drink vs. a placebo drink, researchers from the Mayo Clinic found.
High levels of lipids such as cholesterol and triglycerides may prolong the amount of time it takes for vitamin E to be absorbed from the bloodstream, according to research appearing in the American Journal of Clinical Nutrition.
The Food and Drug Administration (FDA) is warning consumers to not buy or use Diablos Eca Fire Caps, Stiff Nights, La Pepa Negra, and Herb Viagra, which are marketed for sexual enhancement.
The FDA is warning consumers to not buy or use Black Mamba Hyperrush, Lean Body Extreme, and Natural Max Slimming weight loss supplements.
UltraZx Labs announced a voluntary recall of all lots of UltraZx, dietary supplements promoted for weight loss, due to the presence of undeclared ingredients.
Food product labels that include traffic light symbols to convey health-related information may be more effective in helping consumers resist high-calorie foods compared to information-based labels
New Phase 3a data indicates that overweight or obese adults with comorbidities had greater improvements in weight loss, fasting plasma glucose (FPG), systolic blood pressure (SPB), and physical health scores with Saxenda (liraglutide [rDNA origin] injection; Novo Nordisk) compared to non-responders and those on placebo treatment.
Hospira has announced a voluntary recall of one lot of Magnesium Sulfate in 5% Dextrose 10mg/mL Injection after confirmed customer reports of an incorrect barcode on the primary bag labeling.
The Food and Drug Administration (FDA) has announced results from its milk sampling survey of nearly 2,000 dairy farms regarding drug residues in milk.
In an updated position paper, the Academy of Nutrition and Dietetics stated that breastfeeding provides the best nutrition for infants and very young children.
A synthetic nasal formulation of the hormone oxytocin could help to reduce caloric intake after a study showed promising results for healthy men.
Consuming Coenzyme Q10 (ubiquinone), a common dietary supplement, may not be very beneficial, new research suggests.
Hospira announced a voluntary nationwide recall of one lot of 0.9% Sodium Chloride Injection VisIV flex container following a confirmed customer report of particulate in a single unit.
The Food and Drug Administration (FDA) is warning consumers to not buy or use Black Ant King, Black Mamba Premium, African Superman, and Bigger Longer More Time More Sperms (sic), which are all marketed for sexual enhancement.
Candy consumers may want to not over-indulge in licorice, as the candy has been associated with tonic-clonic seizures in a new case study published in the journal Pediatric Neurology.
A newly discovered hormone has been shown to restore insulin sensitivity in muscle tissue and could help to counteract diet-induced and age-dependent insulin resistance.
Adults and children are recommended to reduce their daily intake of free sugars to less than 10% of total energy intake, according to a new guideline released by the World Health Organization (WHO).
The Food and Drug Administration (FDA) has issued a warning to not buy or use Elimulating Weight & Toxin Keeping Beauty and L-Carnitine Sob Strengthening Version Slimming Miracle Capsule, which are products promoted for weight loss.
The Food and Drug Administration (FDA) is warning consumers to not use or buy SEx Men, Super Hard, Santi Scalper, Vigra, Plant Vigra, Vigour 300, MME MAXMAN, Hard Wang, FX3000 after they were found to contain hidden drug ingredients.
The Food and Drug Administration (FDA) has warned against the use of Libigrow XXX Treme, Night Man, Black King Kong, 72HP, Tibet Babao, and Germany Niubian supplements promoted for sexual enhancement.
The FDA has warned consumers to not buy or use the weight loss supplements Oxy ELITE Pro Super Thermogenic, Nine Slim, Seven Slim, and Botanical Slimming (Red) after they were found to contain undeclared drug ingredients.
The FDA has accepted for Priority Review the Biologics License Application (BLA) for asfotase alfa in the treatment of patients with infantile-and juvenile-onset hypophosphatasia (HPP).
GlaxoSmithKline announced that alli (orlistat) capsules have returned to most stores in the United States and Puerto Rico following the voluntary recall in March 2014.
Pregnant women with various classes of obesity should not gain any weight until mid-pregnancy or later for optimal pregnancy outcomes, according to a new study in the journal Obesity.
Nurture, not nature, may play a greater role in childhood obesity as researchers have found that environment may be an equal (if not stronger) force in determining obesity compared to the mother's diet.
Compared to healthy individuals, women with multiple sclerosis (MS) may have lower levels of key antioxidant and anti-inflammatory nutrients such as folate and vitamin E.
The U.S. Department of Health and Human Services (HHS) has announced that the 2015 Dietary Guidelines Advisory Committee (DGAC) has submitted recommendations to HHS Secretary Sylvia M. Burwell and Agriculture Secretary Tom Vilsack for the 2015 edition of the Dietary Guidelines for Americans.
New research published in The Journal of Pediatrics suggests that a plant-based, low-fat vegan diet can significantly reduce risk factors for cardiovascular disease in obese children.
Genzyme announced results from its extension study of the Phase 3 ENGAGE and ENCORE studies of Cerdelga (eliglustat) for the treatment of certain adults with Gaucher disease type 1.
Increased cranberry juice consumption has been linked to lower levels of C-reactive protein (CRP), a marker of inflammation.
Iron supplementation, compared to no supplementation, significantly reduced time to recovery of lost iron and hemoglobin after a blood donation, according to a new study.
Detox Transforms Health and Nutrition announced a voluntary recall of 5 dietary supplements after they were found to contain undeclared drug ingredients.
Advanced Inhalation Therapies announced that the Food and Drug Administration (FDA) has granted Orphan Drug designation to AIT-CF, a high dose formulation of nitric oxide for adjunctive treatment of cystic fibrosis (CF).
New York Attorney General Eric T. Schneiderman has requested that four major retailers in New York cease sales of certain store brand herbal supplements after the presence of the labeled substance could not be verified or the supplements were found to contain ingredients not listed on the labels.
The Food and Drug Administration (FDA) is warning consumers to not buy or use Yanhee Slim, a dietary supplement promoted for weight loss.
Super Bowl Sunday is reported to be the second biggest food day for Americans after Thanksgiving, with the average American consuming as much as 2,400 calories during the game.
A new international collaboration published in The Lancet Psychiatry is encouraging the fields of psychiatry and public health to recognize the relationships between diet quality, potential nutritional deficiencies, and mental health.
A new oral therapy that combines a probiotic and peanut protein appears to be a successful immunotherapy for peanut allergy, based on a study conducted by researchers at Murdoch Childrens Research Institute at the Royal Children's Hospital in Australia.
Hospira announced a voluntary recall of one lot of 0.9% Sodium Chloride Injection due to particulate matter sealed in the bag at the additive port area. The particulate matter was identified as a human hair.
The Food and Drug Administration (FDA) is advising consumers to not buy or use Happy Passengers, a product promoted and sold for sexual enhancement.
New research by the Centers for Disease Control and Prevention (CDC) supports the protective effect of folic acid supplementation against recurrent neural tube defects (NTD).
The Endocrine Society has issued a Clinical Practice Guideline (CPG) on pharmacological strategies for managing obesity and promoting weight loss.
Brown adipose tissue was successfully activated and energy expenditure increased in 12 lean adult men treated with mirabegron in a new study.
The Food and Drug Administration (FDA) has approved EnteroMedics' VBLOC vagal blocking therapy, delivered via the Maestro System, which is the first weight loss treatment device that targets the nerve pathway between the brain and the stomach that controls feelings of hunger and fullness.
New research in the Journal of the American Heart Association suggests that inclusion of one avocado per day as part of a moderate-fat diet may help to improve specific blood lipid markers compared to an energy-matched moderate-fat diet without avocado or a low-fat diet with avocado.
Researchers at the Salk Institute for Biological Studies have developed a compound that targets the farnesoid X receptor (FXR) in the intestines and may help to reduce diet-induced weight gain, body-wide inflammation, and hepatic glucose production while enhancing thermogenesis and browning of white adipose tissue (WAT).
Vertex announced that the FDA has approved the use of Kalydeco (ivacaftor) in patients with cystic fibrosis (CF) ages 6 years and older who have the R117H mutation in the CFTR gene.
Novo Nordisk announced that the FDA has approved Saxenda (liraglutide [rDNA origin]) injection for chronic weight management.
The Food and Drug Administration (FDA) is warning consumers to not buy or use Slim-K, a product marketed for weight loss.
Bethel Nutritional Consulting announced a voluntary recall of B-Lipo Capsules, an herbal supplement marketed for weight loss.
The Food and Drug Administration (FDA) has granted Orphan Drug designation to Translarna (ataluren) for the treatment of patients with Mucopolysaccharidosis I (MPS I).
In a new study published in the Journal of the American Medical Association, diets with low glycemic index of dietary carbohydrate do not appear to lead to a reduction in cardiovascular disease risk or improvement in insulin sensitivity.
Baxter announced a voluntary recall of two lots of 0.9% Sodium Chloride Injection due to particulate matter found in the solution. The particulate matter was identified as a fragment of the frangible from the vial adapter.
The Food and Drug Administration (FDA) has issued a warning regarding the risks associated with the use of dietary supplements containing live bacteria or yeast in immunocompromised persons following the death of a premature infant administered the dietary supplement ABC Dophilus Powder (Solgar), which is formulated to contain three species of live bacteria.
The Food and Drug Administration (FDA) is warning consumers to not buy or use Slim-Vie, a supplement marketed for weight loss.
As required by the 2010 Patient Protection and Affordable Care Act, the FDA finalized that calorie information be listed on menus and menu boards in chain restaurants, similar retail food establishments, and vending machines with 20 or more locations.
The Food and Drug Administration (FDA) is warning consumers not to buy or use "Feng Shi Ling," a product marketed as an herbal drug for pain due to rheumatoid arthritis and osteoporosis.
REFA Enterprises, LLC announced a voluntary recall of Forever Beautiful Bee Pollen and Forever Beautiful Infinity products after they were found to contain undeclared ingredients. Both products are marketed as dietary supplements for weight loss.
According to research presented at the American Heart Association's Scientific Sessions 2014, adults whose mothers were overweight or obese pre-pregnancy may have a significantly increased risk of dying from heart disease or stroke.
New research presented at the American Heart Association's Scientific Session 2014 shows that high trans fat consumption is associated with worse memory among working-age men.
Patients with chronic obstructive pulmonary disease (COPD) aged ≥65 years who received nutrition treatment had reduced lengths of stay, hospital costs, and probability of readmission within 30-days, according to results of a study published in CHEST.
Solgar announced a voluntary recall of ABC Dophilus Powder due to the discovery of Rhizopus oryzae, which may cause Mucormycosis.
The Food and Drug Administration (FDA) is warning consumers not to buy or use Mayhem, a dietary supplement marketed to increase appetite and muscle growth after it was found to contain an undeclared corticosteroid and antihistamine.
Vertex announced that it has submitted a New Drug Application (NDA) to the Food and Drug Administration (FDA) for the combination product lumacaftor and ivacaftor for people with cystic fibrosis (CF) ages ≥12 who have two copies of the F508del mutation in the cystic fibrosis transmembrance conductance regulator (CFTR) gene.
The Food and Drug Administration (FDA) is warning consumers to not buy or use V26 Slimming Coffee, a product sold for weight loss.
The Food and Drug Administration (FDA) has granted Orphan Drug designation to Glassia (alpha1-proteinase inhibitor [human]) for the treatment of Graft-versus-host disease (GVHD).
Takeda and Orexigen announced that Contrave (naltrexone HCl and bupropion HCl) extended-release tablets are now available by prescription.
Hospira announced a voluntary recall of various lots of several intravenous (IV) solutions in its LifeCare line due to potential for leakage.
The conversion of white adipose tissue (WAT) to beige fat as a biological response to cold temperatures may be hindered in overweight individuals, according to a new study published online in the Journal of Clinical Endocrinology & Metabolism.
The Food and Drug Administration (FDA) is advising consumers to not buy or use Sit and Slim II, a product promoted and sold for weight loss.
The United States Marshals seized over 25,000 pounds of raw kratom material valued at more than $5 million from Rosefield Mangement, Inc. in Van Nuys, CA.
The American Association of Clinical Endocrinologist (AACE) and the American College of Endocrinology (ACE) announced the publication of its position statement that describes its framework for a new diagnosis of obesity as a chronic disease.
Baxter announced a voluntary recall of one lot of Potassium Chloride Injection 10mEq/100mL at the hospital/pharmacy/nurse level.
The Food and Drug Administration (FDA) has granted Orphan Drug designation to Lynovex (NM001; NovaBiotics) for the treatment of cystic fibrosis (CF).
The Food and Drug Administration (FDA) is warning consumers that several products promoted and sold for weight loss have been found to contain undeclared ingredients and should not be purchased or used.
The Food and Drug Administration (FDA) has accepted for filing Shire's supplemental New Drug Application (sNDA) with priority review for Vyvanse (lisdexamfetamine dimesylate) Capsules (CII) for the treatment of adults with binge eating disorder (BED).
A Food and Drug Administration (FDA) Advisory Committee has voted in favor of recommending liraglutide for chronic weight management in individuals with obesity or who are overweight with at least one weight-related comorbidity
Takeda and Orexigen announced that the Food and Drug Administration (FDA) has approved Contrave (naltrexone HCl and bupropion HCl) extended-release tablets as adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults
Over 90% of school-age children in the United States are consuming more than the recommended daily allowance of sodium, with 10 common food types contributing to over 40% of the total sodium consumed by children, according to the Centers for Disease Control and Prevention (CDC).
Obese adults may be more susceptible to environmental food cues than lean adults due to differences in brain chemistry that make eating more habitual and less rewarding, according a new study.
- Necessary Procedure Leads to Assault and Battery Charges
- Certain Antibiotics May Up Diabetes Risk
- FDA: Life-Threatening Interaction Possible Between Antivirals, Amiodarone
- Study: Abuse, Addiction, Poisoning Diagnoses Decrease with Reformulated Oxycontin
- Spironolactone for Hormonal Acne: Is Routine Potassium Monitoring Necessary?
- Public Health Emergency Declared in IN Following HIV Outbreak
- Study: Hospital Readmissions, Length of Stay Greater for C. diff Patients
- Does the Aviation Industry Need Better Mental Health Screening?
- National Strategy to Fight Superbugs Released by the White House
- Gene Mutation May Explain Severe Flu in Healthy Children